Cardoso R, Graffunder FP, Ternes CM, Fernandes A, Rocha AV, Fernandes G, Bhatt DL
Our findings strongly support a need for further investigation to safeguard public health." In response to the study, a Novo Nordisk spokesperson told LADbible Group: "Patient safety is our top priority and we will continue to monitor reports of adverse drug reactions, including suicide and suicidal ideation, through routine pharmacovigilance
Just make sure you stay in lockstep with your healthcare provider.
How does semaglutide compare to liraglutide and tirzepatide in terms of weight loss efficacy and adverse effects across the clinical trials
However, it is unclear whether their potential benefits for AF are primarily driven by weight reduction or whether the medications may have additional independent cardiovascular effects
Why GLP-1 users are at higher risk Several factors increase the risk of B6 depletion during GLP-1 therapy